- Home
- VSTM vs JEQ Comparison
VSTM vs JEQ Comparison
Compare VSTM & JEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTM
- JEQ
- Stock Information
- Founded
- VSTM 2010
- JEQ 1990
- Country
- VSTM United States
- JEQ United States
- Employees
- VSTM N/A
- JEQ N/A
- Industry
- VSTM Biotechnology: Pharmaceutical Preparations
- JEQ Air Freight/Delivery Services
- Sector
- VSTM Health Care
- JEQ Consumer Discretionary
- Exchange
- VSTM Nasdaq
- JEQ Nasdaq
- Market Cap
- VSTM 425.9M
- JEQ 99.8M
- IPO Year
- VSTM 2012
- JEQ N/A
- Fundamental
- Price
- VSTM $4.88
- JEQ $7.23
- Analyst Decision
- VSTM Strong Buy
- JEQ
- Analyst Count
- VSTM 9
- JEQ 0
- Target Price
- VSTM $12.63
- JEQ N/A
- AVG Volume (30 Days)
- VSTM 2.6M
- JEQ 32.0K
- Earning Date
- VSTM 08-07-2025
- JEQ 01-01-0001
- Dividend Yield
- VSTM N/A
- JEQ 7.05%
- EPS Growth
- VSTM N/A
- JEQ N/A
- EPS
- VSTM N/A
- JEQ N/A
- Revenue
- VSTM $10,000,000.00
- JEQ N/A
- Revenue This Year
- VSTM $129.06
- JEQ N/A
- Revenue Next Year
- VSTM $306.32
- JEQ N/A
- P/E Ratio
- VSTM N/A
- JEQ N/A
- Revenue Growth
- VSTM N/A
- JEQ N/A
- 52 Week Low
- VSTM $2.10
- JEQ $4.99
- 52 Week High
- VSTM $9.10
- JEQ $6.39
- Technical
- Relative Strength Index (RSI)
- VSTM 39.75
- JEQ 51.52
- Support Level
- VSTM $4.58
- JEQ $7.24
- Resistance Level
- VSTM $4.90
- JEQ $7.62
- Average True Range (ATR)
- VSTM 0.29
- JEQ 0.09
- MACD
- VSTM 0.10
- JEQ -0.02
- Stochastic Oscillator
- VSTM 66.67
- JEQ 51.47
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About JEQ abrdn Japan Equity Fund Inc.
Aberdeen Japan Equity Fund Inc is a United States-based closed-end diversified management investment company. Its investment objective is to outperform over the long term, on a total return basis (including appreciation and dividends), the Tokyo Stock Price Index ("TOPIX"). The fund seeks to achieve its investment objective by investing a majority of its assets, in equity securities of companies listed on the Tokyo Stock Exchange or listed on the over-the-counter market in Japan or listed on other stock exchanges in Japan. The portfolio of investments is spread across Consumer Discretionary, Industrials, Information Technology, Financials, and other sectors.